EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.5.1.19 | Tuberculosis |
330364 |
Cytochemical and biological properties of Mycobacterium bovis BCG. |
diagnostic usage unassigned |
3 0 |
3.5.1.19 | Photophobia |
506551 |
[Nicotinamidase and the so-called pyrazinamidase in mycobacteria; the simultaneous occurrence of both activites (author's transl)] |
unassigned |
0 |
3.5.1.19 | Leprosy |
3546548 |
Identification of cat leprosy bacillus grown in mice. |
unassigned |
0 |
3.5.1.19 | Neoplasms |
4259432 |
Early effects of nicotinamide, 2,4-dichloro-phenoxy acetic acid & actinomycin-D on the synthesis of nicotinamide amidohydrolase in rumex acetosa tumour tissue. |
ongoing research unassigned |
1 0 |
3.5.1.19 | Neuroblastoma |
7378417 |
Purification and characterization of a nicotinamide deamidase released into the growth medium of neuroblastoma in vitro. |
ongoing research unassigned |
4 0 |
3.5.1.19 | Tuberculosis |
8640557 |
Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. |
therapeutic application unassigned |
1 0 |
3.5.1.19 | Tuberculosis |
8726014 |
Identification, cloning, and expression of the Escherichia coli pyrazinamidase and nicotinamidase gene, pncA. |
diagnostic usage unassigned |
3 0 |
3.5.1.19 | Tuberculosis |
8968889 |
Rapid differentiation of bovine and human tubercle bacilli based on a characteristic mutation in the bovine pyrazinamidase gene. |
diagnostic usage ongoing research therapeutic application unassigned |
3 2 1 0 |
3.5.1.19 | Tuberculosis |
9055989 |
Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. |
therapeutic application unassigned |
1 0 |
3.5.1.19 | Tuberculosis |
9353938 |
The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms. |
ongoing research therapeutic application unassigned |
2 1 0 |